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Abstract
Perineural invasion (PNI) is an underrecognized path of
cancer spread, and its causes and mechanisms are poorly
understood. Recent research indicates a mutual attraction
of neuronal and cancer cells, largely dependent on neuro-
trophic factors and their receptors. Interestingly, the release
of neurotrophic factors occurs upon cigarette smoke/nico-
tine exposure in a dose-dependent manner, and serum
levels correlate with current smoking, number of smoking
years, and smoking severity. Among cell types capable of
neurotrophic factors secretion are lung and oral fibroblasts.
In our study of 178 patients with head and neck squamous
cell carcinoma, tumors of current and former smokers
showed PNI significantly more often than tumors of never
smokers. Moreover, PNI was a marker for aggressive tumor
growth. Surprisingly, PNI was more significant for survival
than p16 status. Our study warrants further research on
PNI in head and neck squamous cell carcinoma with special
emphasis on the impact of tobacco consumption to identify
suitable candidates for therapeutic interventions.
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P
erineural invasion (PNI) represents a specific path of
cancer spread in a variety of solid malignancies,
including head and neck squamous cell carcinoma
(HNSCC), and is associated with poor prognosis.1-4
Perineural growth occurs in a discontinuous manner.
Cancers spread centripetally toward the central nervous
system, forming skip lesions.5 Thus, PNI-positive (Pn1)
HNSCCs may be particularly difficult to resect.6 PNI also
represents a characteristic of more aggressive carcinomas.7
Causes and mechanisms of PNI are poorly understood.
Recent research indicates that a mutual tropism between
pancreatic cancer cells and neurons induces PNI.8 Deborde et
al discovered a subpopulation of Schwann cells in murine and
human specimens that associate with pancreatic cancer cells.9
In cocultures with dorsal root ganglion extracts, these
Schwann cells directed cancer cells to migrate toward nerves
in a contact-dependent manner. The neural cell adhesion mole-
cule (NCAM), activated by hemophilic binding, was expressed
on both Schwann and cancer cells. In their study, cancer cell
dispersion and directed invasion of cancer cells were depen-
dent on NCAM expression of Schwann cells. NCAM is
expressed by 93% of Pn1-HNSCCs.10 NCAM is also an alter-
native receptor of glial cell–derived neurotrophic factor
(GDNF), and cancer cell invasion of neuronal structures is par-
tially dependent of GDNF secretion of neuronal cells.11,12
Furthermore, nerve growth factor (NGF), brain-derived neuro-
trophic factor (BDNF), and their respective receptors,
tropomyosin-related kinase A and B (TrkA and TrkB), are
involved in PNI.13
Very recent studies indicated a role of the neurotrophic
factors in smoking and the development of nicotine depen-
dence.14,15 The aim of our study was to investigate possible
associations between smoking and PNI in HNSCC.
Methods
We retrospectively analyzed PNI in the HNSCC of patients
prospectively enrolled in our department in an ongoing
study about risk factors of HNSCC.16 Patients were inter-
viewed about smoking habits on the day before surgical
resection of their tumors. Former smokers were defined as
patients who stopped smoking at least 1 year before diagno-
sis. All patients signed an informed consent regarding the
use of clinical data. The study was approved by the Ethics
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Committee of the Medical Faculty of Ludwig-Maximilians-
University, Munich, Germany. Statistical analysis performed
with SPSS 24 (IBM, Chicago, Illinois).
Results
A total of 178 cases were analyzed. Clinical data are shown
in Table 1: 27.5% (n = 49) of tumors were diagnosed as
Pn1 and 72.5% (n = 129) as Pn0. PNI was detected signifi-
cantly more often in HNSCC of current (34.7%, n = 95) and
former (26.1%, n = 46) smokers as compared with never
smokers (10.3%, n = 29; P = .036, chi-square test; see
Figure 1). Spearman correlation between smoking status
and PNI was also significant (P = .014).
In the p16-negative group, PNI was found in the tumors
of 30.9%, 25.0%, and 0% of current, former, and never
smokers, respectively; these percentages were 19.0%,
17.6%, and 4.8%, respectively, in the p16-positive group.
Overall, 26.4% of p16-negative and 12.9% of p16-positive
HNSCCs were diagnosed as Pn1 (P = .045, chi-square test).
Noteworthy, Pn1-HNSCC significantly more often showed
additional signs of aggressive growth in terms of lympho-
vascular invasion (40.0% vs 17.9%, P = .001, chi-square
test), vein invasion (64.3% vs 23.0%, P = .001, chi-square
test), and extranodal extension (37.3% vs 12.7%, P = .025,
chi-square test).
Median follow-up was 2.0 years (range, 0.6-7.0 years).
Patients with Pn1-HNSCC had a significantly shorter disease-
free survival (3.9 years [95% CI, 2.9-4.9] vs 5.1 years [95%
CI, 4.5-5.7], P = .013276, log-rank test) and overall survival
(3.0 years [95% CI, 2.2-3.8] vs 5.4 years [95% CI, 4.8-5.9],
P = .000004, log-rank test; see Figure 2). Surprisingly,
patients with p16-positive HNSCC did not have a longer
disease-free survival (5.0 years [95% CI, 4.3-5.7] vs 4.1
years [95% CI, 3.6-4.6], P = .170799, log-rank test) within
this follow-up period. Overall survival of patients with p16-
positive HNSCC was significantly longer (5.8 years [95% CI,
5.2-6.3] vs 3.7 years [95% CI, 3.2-4.3], P = .001297, log-
rank test). In multivariate analysis, PNI (P = .000661, Cox
regression) was more significant for overall survival when
compared with p16 (P = .006185, Cox regression).
Discussion
Our results suggest an association between tobacco con-
sumption and PNI in HNSCC. Furthermore, PNI was related
to established characteristics of aggressive tumor growth.
PNI is dependent on the presence of neurotrophic factors.4
Higher expression levels of NGF and its receptor TrkA were
detected in Pn1 versus Pn0 HNSCC.17 TrkB and GDNF were
more expressed in HNSCC tumor specimens than in surround-
ing mucosa. Blockade of NGF/TrkA signaling decreased pro-
liferation of cancer cells.18,19 GDNF increased matrix
metalloproteinase expression and, thus, migration of oral
cancer cells.20 As reviewed recently, BDNF/TrkB signaling
regulates cell migration, invasion, epithelial-to-mesenchymal
transition, and cisplatin resistance in HNSCC.21
Table 1. Clinical Data.
n (%)
Localization
Oral cavity 33 (18.5)
Oropharynx 128 (71.9)
Hypopharynx 13 (7.3)
Larynx 4 (2.2)
Smoking
Current 29 (16.3)
Former 46 (25.8)
Never 95 (53.4)
N/A 8 (4.5)
T-staginga
pT1 23 (12.9)
pT2 78 (43.8)
pT3 66 (37.1)
pT4a 10 (5.6)
pTx 1 (0.6)
N-staginga
pN0 52 (29.2)
pN1 22 (12.4)
pN2a 16 (9.0)
pN2b 47 (26.4)
pN2c 22 (12.4)
pN3 3 (1.7)
pNx 16 (9.0)
p16
Positive 62 (34.4)
Negative 87 (48.9)
N/A 29 (16.3)
Perineural invasion
Pn0 (absent) 129 (72.5)
Pn1 (present) 49 (27.5)
Lymphovascular invasion
L0 (absent) 106 (59.6)
L1 (present) 70 (39.3)
N/A 2 (1.1)
Vein invasion
V0 (absent) 161 (90.4)
V1 (present) 14 (7.9)
N/A 3 (1.7)
Extranodal extension
Positive 51 (28.7)
Negative 51 (28.7)
N0b 67 (37.6)
N/A 9 (5.0)
Grading
G1 4 (2.2)
G2 57 (32.0)
G3 117 (65.7)
Abbreviation: N/A, not available.
aAJCC Cancer Staging Manual, 7th Edition.
bClinically or pathologically N0.
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There is growing evidence of an association between
neurotrophic factors and smoking. BDNF influences nico-
tine dependence. Current smoking and higher number of
smoking years were associated with higher BDNF serum
levels.14 BDNF serum levels also correlated with exhaled
carbon monoxide and, therefore, smoking severity.22 BDNF
is released from blood platelets exposed to cigarette smoke
in a dose-dependent manner.23 It is secreted by airway
smooth muscle cells and lung fibroblasts upon cigarette
smoke/nicotine exposure.24,25 Duda´s et al showed that oral
fibroblasts are capable of producing BDNF.26
In summary, a link among tobacco consumption, neu-
rotrophic factors, and PNI in HNSCC seems plausible,
even though other causative factors may play a role. Our
results indicate a link between smoking and PNI—to our
knowledge for the first time—and so warrant further
investigations into proposed connections, not least to
identify suitable candidates and targets for therapeutic
interventions.
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